Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引:12
|
作者
Kanters, T. A. [1 ,2 ]
Redekop, W. K. [1 ]
Kruijshaar, M. E. [2 ,3 ]
van der Ploeg, A. T. [2 ,3 ]
Rutten-van Molken, M. P. M. H. [1 ]
Hakkaart, L. [1 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC Univ, Med Ctr, Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands
[3] Erasmus MC Univ, Med Ctr Rotterdam, Dept Pediat, Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands
关键词
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease; Pompe disease; HEALTH; ADULTS; INSTRUMENTS; PROGRESSION; VALIDITY; EUROQOL; IMPACT;
D O I
10.1007/s11136-014-0833-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan disease with a prevalence of < 5/10,000, characterized by impaired ambulatory and pulmonary functioning. We compared the psychometric properties of EQ-5D and SF-6D in patients with this disease and assessed their convergent validity, discriminative ability and sensitivity to change. EQ-5D utilities and SF-6D utilities were computed using the UK value set. Dimensions and utilities of the two instruments were compared by correlation coefficients and descriptive statistics. We assessed whether EQ-5D and SF-6D were able to discriminate between different levels of severity and examined sensitivity to change for patients with multiple observations. Correlations between theoretically related dimensions of the EQ-5D and SF-6D were highly significant and were moderate to strong (range rho = 0.409-0.564). Utility values derived from the two instruments were similar (mean EQ-5D = 0.670; mean SF-6D = 0.699) and correlated strongly (rho = 0.591). Discriminative properties were somewhat better for EQ-5D; mean changes and effect sizes were better for SF-6D. Overall, we conclude that both instruments appear to be equally appropriate with respect to assessing utilities in Pompe disease, but neither of them performed excellently. The descriptive system of the SF-6D describes health states for Pompe disease more accurately. EQ-5D showed better discriminative properties. The SF-6D performed better with respect to sensitivity to change.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 50 条
  • [1] Comparison of EQ-5D and SF-6D utilities in Pompe disease
    T. A. Kanters
    W. K. Redekop
    M. E. Kruijshaar
    A. T. van der Ploeg
    M. P. M. H. Rutten-van Mölken
    L. Hakkaart
    Quality of Life Research, 2015, 24 : 837 - 844
  • [2] Comparing SF-6D and EQ-5D utilities across groups differing in health status
    Kontodimopoulos, Nick
    Pappa, Evelina
    Papadopoulos, Angelos A.
    Tountas, Yannis
    Niakas, Dimitris
    QUALITY OF LIFE RESEARCH, 2009, 18 (01) : 87 - 97
  • [3] A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Chen, Jing
    Wong, Carlos K. H.
    McGhee, Sarah M.
    Pang, Polly K. P.
    Yu, Wai-Cho
    PLOS ONE, 2014, 9 (11):
  • [4] The Responsiveness of Quality of Life Utilities to Change in Depression: A Comparison of Instruments (SF-6D, EQ-5D, and DFD)
    Gerhards, Sylvia A. H.
    Huibers, Marcus J. H.
    Theunissen, Kevin A. T. M.
    de Graaf, L. Esther
    Widdershoven, Guy A. M.
    Evers, Silvia M. A. A.
    VALUE IN HEALTH, 2011, 14 (05) : 732 - 739
  • [5] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Kontodimopoulos, Nick
    Argiriou, Michalis
    Theakos, Nikolaos
    Niakas, Dimitris
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (04) : 383 - 391
  • [6] Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
    Yousefi, Mahmood
    Najafi, Safa
    Ghaffari, Shahram
    Mahboub-Ahari, Alireza
    Ghaderi, Hossein
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (05)
  • [7] Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS
    Stavem, K
    Froland, SS
    Hellum, KB
    QUALITY OF LIFE RESEARCH, 2005, 14 (04) : 971 - 980
  • [8] Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS
    Knut Stavem
    Stig S. Frøland
    Kjell B. Hellum
    Quality of Life Research, 2005, 14 : 971 - 980
  • [9] Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D
    Bjerk, Maria
    Brovold, Therese
    Davis, Jennifer C.
    Bergland, Astrid
    QUALITY OF LIFE RESEARCH, 2019, 28 (12) : 3187 - 3195
  • [10] Is there a difference between EQ-5D and SF-6D in the clinical setting? a comparative study on the quality of life measured by AIMS2-SF, EQ-5D and SF-6D scales for osteoarthritis patients
    Zhang, Fang
    Yang, Yu
    Huang, Tao
    Zhang, Yiye
    Zhao, Li
    Li, Shuchuen
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (06) : 1185 - 1192